| Year |
Citation |
Score |
| 2020 |
Hall S, Howell J, Visvanathan K, Thompson A. The Yin and the Yang of Treatment for Chronic Hepatitis B-When to Start, When to Stop Nucleos(t)ide Analogue Therapy. Viruses. 12. PMID 32854335 DOI: 10.3390/V12090934 |
0.313 |
|
| 2020 |
Yuen L, Revill PA, Rosenberg G, Wagner J, Littlejohn M, Bayliss J, Jackson K, Tan SK, Gaggar A, Kitrinos K, Subramanian M, Gane E, Chan HL, Li X, Bowden S, ... ... Thompson A, et al. HBV variants are common in the "immune-tolerant"phase of chronic hepatitis B. Journal of Viral Hepatitis. PMID 32384174 DOI: 10.1111/Jvh.13318 |
0.308 |
|
| 2019 |
Dore GJ, Feld JJ, Thompson A, Martinello M, Muir AJ, Agarwal K, Müllhaupt B, Wedemeyer H, Lacombe K, Matthews GV, Schultz M, Klein M, Hezode C, Estivill Mercade G, Kho D, et al. Simplified monitoring for hepatitis C virus treatment with glecaprevir plus pibrentasvir, a randomised non-inferiority trial. Journal of Hepatology. PMID 31655134 DOI: 10.1016/J.Jhep.2019.10.010 |
0.325 |
|
| 2019 |
Papaluca T, Sinclair M, Gow P, Pianko S, Sievert W, Arachchi N, Cameron K, Bowden S, O'Keefe J, Doyle J, Stoove M, Hellard M, Iser D, Thompson A. Retreatment with Elbasvir, Grazoprevir, Sofosbuvir +/- Ribavirin is effective for GT3 and GT1/4/6 HCV infection after relapse. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 31355968 DOI: 10.1111/Liv.14201 |
0.318 |
|
| 2019 |
Hutton J, Doyle J, Zordan R, Weiland T, Cocco A, Howell J, Iser S, Snell J, Fry S, New K, Sloane R, Jarman M, Phan D, Tran S, Pedrana A, ... ... Thompson A, et al. Point-of-care Hepatitis C virus testing and linkage to treatment in an Australian inner-city emergency department. The International Journal On Drug Policy. PMID 31351752 DOI: 10.1016/J.Drugpo.2019.06.021 |
0.321 |
|
| 2019 |
Sasadeusz J, Grigg A, Hughes PD, Lee Lim S, Lucas M, McColl G, McLachlan SA, Peters MG, Shackel N, Slavin M, Sundararajan V, Thompson A, Doyle J, Rickard J, De Cruz P, et al. Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Other Populations and Newer Agents. Clinics in Liver Disease. 23: 521-534. PMID 31266625 DOI: 10.1016/J.Cld.2019.04.012 |
0.309 |
|
| 2019 |
Sasadeusz J, Grigg A, Hughes PD, Lee Lim S, Lucas M, McColl G, McLachlan SA, Peters MG, Shackel N, Slavin M, Sundararajan V, Thompson A, Doyle J, Rickard J, De Cruz P, et al. Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Introduction and Immunology. Clinics in Liver Disease. 23: 487-492. PMID 31266622 DOI: 10.1016/J.Cld.2019.04.009 |
0.331 |
|
| 2019 |
Herndon EM, Kinsman‐Costello L, Duroe KA, Mills J, Kane ES, Sebestyen SD, Thompson AA, Wullschleger SD. Iron (Oxyhydr)Oxides Serve as Phosphate Traps in Tundra and Boreal Peat Soils Journal of Geophysical Research: Biogeosciences. 124: 227-246. DOI: 10.1029/2018Jg004776 |
0.301 |
|
| 2018 |
Howell J, Pedrana A, Cowie BC, Doyle J, Getehun A, Ward J, Gane E, Cunningham C, Wallace J, Lee A, Malani J, Thompson A, Hellard ME. Aiming for the elimination of viral hepatitis in Australia, New Zealand, the Pacific Islands and Territories: where are we now and barriers to meeting WHO targets by 2030. Journal of Gastroenterology and Hepatology. PMID 30151932 DOI: 10.1111/Jgh.14457 |
0.318 |
|
| 2018 |
Goutzamanis S, Doyle JS, Thompson A, Dietze P, Hellard M, Higgs P. Experiences of liver health related uncertainty and self-reported stress among people who inject drugs living with hepatitis C virus: a qualitative study. Bmc Infectious Diseases. 18: 151. PMID 29609552 DOI: 10.1186/S12879-018-3057-1 |
0.312 |
|
| 2018 |
Coward EK, Thompson A, Plante AF. Contrasting Fe speciation in two humid forest soils: Insight into organomineral associations in redox-active environments Geochimica Et Cosmochimica Acta. 238: 68-84. DOI: 10.1016/J.Gca.2018.07.007 |
0.321 |
|
| 2017 |
Scott N, Doyle JS, Wilson DP, Wade A, Howell J, Pedrana A, Thompson A, Hellard ME. Reaching hepatitis C virus elimination targets requires health system interventions to enhance the care cascade. The International Journal On Drug Policy. PMID 28797497 DOI: 10.1016/J.Drugpo.2017.07.006 |
0.309 |
|
| 2017 |
Lubel J, Strasser S, Stuart KA, Dore G, Thompson A, Pianko S, Bollipo S, Mitchell JL, Fragomeli V, Jones T, Chivers S, Gow P, Iser D, Levy M, Tse E, et al. Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir ± ribavirin for hepatitis C genotype 1 - final results of the REV1TAL study. Antiviral Therapy. PMID 28422043 DOI: 10.3851/Imp3168 |
0.302 |
|
| 2016 |
Thompson A, Locarnini S, Revill P. Reply: 'More viral mutants, less HBsAg clearance? One size may not fit all'. Gut. PMID 27884921 DOI: 10.1136/Gutjnl-2016-313287 |
0.305 |
|
| 2016 |
Bayliss J, Yuen L, Rosenberg G, Wong D, Littlejohn M, Jackson K, Gaggar A, Kitrinos KM, Subramanian GM, Marcellin P, Buti M, Janssen HL, Gane E, Sozzi V, Colledge D, ... ... Thompson A, et al. Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B. Gut. PMID 27534671 DOI: 10.1136/Gutjnl-2015-309300 |
0.313 |
|
| 2016 |
Hajarizadeh B, Grebely J, McManus H, Estes C, Razavi H, Gray RT, Alavi M, Amin J, McGregor S, Sievert W, Thompson A, Dore GJ. Chronic hepatitis C burden and care cascade in Australia in the era of interferon-based treatment. Journal of Gastroenterology and Hepatology. PMID 27197716 DOI: 10.1111/Jgh.13453 |
0.323 |
|
| 2016 |
Martinello M, Hellard M, Shaw D, Petoumenos K, Applegate T, Grebely J, Yeung B, Maire L, Iser D, Lloyd A, Thompson A, Sasadeusz J, Haber P, Dore GJ, Matthews GV. Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: the ATAHC II and DARE-C I studies. Antiviral Therapy. PMID 26867206 DOI: 10.3851/Imp3035 |
0.322 |
|
| 2016 |
Hezode C, Dore GJ, Pianko S, Pol S, Stuart K, Thompson A, Tse E, Bhore R, Jimenez-Exposito MJ. Su1424 Daclatasvir Plus Sofosbuvir Plus Ribavirin for 12 or 16 Weeks in Treatment-Experienced Patients With HCV Genotype 3 Infection and Advanced Fibrosis or Cirrhosis Gastroenterology. 150. DOI: 10.1016/S0016-5085(16)33701-5 |
0.304 |
|
| 2015 |
Foster GR, Afdhal N, Roberts SK, Bräu N, Gane EJ, Pianko S, Lawitz E, Thompson A, Shiffman ML, Cooper C, Towner WJ, Conway B, Ruane P, Bourlière M, Asselah T, et al. Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection. The New England Journal of Medicine. PMID 26575258 DOI: 10.1056/Nejmoa1512612 |
0.319 |
|
| 2015 |
Hellard M, McBryde E, Sacks Davis R, Rolls DA, Higgs P, Aitken C, Thompson A, Doyle J, Pattison P, Robins G. Hepatitis C transmission and treatment as prevention - The role of the injecting network. The International Journal On Drug Policy. PMID 26072105 DOI: 10.1016/J.Drugpo.2015.05.006 |
0.304 |
|
| 2015 |
Thompson A, Roberts S, Cheng W, Angus P, Visvanathan K, Iyer R, Barclay M. LP40 : SB 9200, A novel immunomodulator for patients with viral hepatitis: Phase 1 mad study in patients with hepatitis c virus (HCV) infection Journal of Hepatology. 62: S283-S284. DOI: 10.1016/S0168-8278(15)30194-X |
0.325 |
|
| 2015 |
Huang L, Thompson A, Zhang G, Chen L, Han G, Gong Z. The use of chronosequences in studies of paddy soil evolution: A review Geoderma. 237: 199-210. DOI: 10.1016/J.Geoderma.2014.09.007 |
0.301 |
|
| 2014 |
Ginn BR, Habteselassie MY, Meile C, Thompson A. Effects of sample storage on microbial Fe-reduction in tropical rainforest soils Soil Biology and Biochemistry. 68: 44-51. DOI: 10.1016/J.Soilbio.2013.09.012 |
0.301 |
|
| 2014 |
Buettner SW, Kramer MG, Chadwick OA, Thompson A. Mobilization of colloidal carbon during iron reduction in basaltic soils Geoderma. 221: 139-145. DOI: 10.1016/J.Geoderma.2014.01.012 |
0.315 |
|
| 2013 |
Thompson A, Amistadi MK, Chadwick OA, Chorover J. Fractionation of yttrium and holmium during basaltic soil weathering Geochimica Et Cosmochimica Acta. 119: 18-30. DOI: 10.1016/J.Gca.2013.06.003 |
0.315 |
|
| 2012 |
Thompson A, Patel K. New agents for the treatment of hepatitis C virus – focus on telaprevir Virus Adaptation and Treatment. 4: 75-84. DOI: 10.2147/Vaat.S12707 |
0.333 |
|
| 2011 |
Chan HL, Thompson A, Martinot-Peignoux M, Piratvisuth T, Cornberg M, Brunetto MR, Tillmann HL, Kao JH, Jia JD, Wedemeyer H, Locarnini S, Janssen HL, Marcellin P. Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report. Journal of Hepatology. 55: 1121-31. PMID 21718667 DOI: 10.1016/J.Jhep.2011.06.006 |
0.3 |
|
| 2011 |
Tillmann HL, Patel K, Muir AJ, Guy CD, Li JH, Lao XQ, Thompson A, Clark PJ, Gardner SD, McHutchison JG, McCarthy JJ. Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis C. Journal of Hepatology. 55: 1195-200. PMID 21703198 DOI: 10.1016/J.Jhep.2011.03.015 |
0.317 |
|
| 2010 |
Rallón NI, Naggie S, Benito JM, Medrano J, Restrepo C, Goldstein D, Shianna KV, Vispo E, Thompson A, McHutchison J, Soriano V. Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients. Aids (London, England). 24: F23-9. PMID 20389235 DOI: 10.1097/Qad.0B013E3283391D6D |
0.314 |
|
| 2010 |
Li JH, Lao XQ, Tillmann HL, Rowell J, Patel K, Thompson A, Suchindran S, Muir AJ, Guyton JR, Gardner SD, McHutchison JG, McCarthy JJ. Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infection. Hepatology (Baltimore, Md.). 51: 1904-11. PMID 20235331 DOI: 10.1002/Hep.23592 |
0.317 |
|
| 2010 |
McCarthy JJ, Li JH, Thompson A, Suchindran S, Lao XQ, Patel K, Tillmann HL, Muir AJ, McHutchison JG. Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin. Gastroenterology. 138: 2307-14. PMID 20176026 DOI: 10.1053/J.Gastro.2010.02.009 |
0.313 |
|
| 2009 |
Thompson AA, Zou A, Yan J, Duggal R, Hao W, Molina D, Cronin CN, Wells PA. Biochemical characterization of recombinant hepatitis C virus nonstructural protein 4B: evidence for ATP/GTP hydrolysis and adenylate kinase activity. Biochemistry. 48: 906-16. PMID 19146391 DOI: 10.1021/Bi801747P |
0.314 |
|
| 2009 |
Geiss BJ, Thompson AA, Andrews AJ, Sons RL, Gari HH, Keenan SM, Peersen OB. Analysis of flavivirus NS5 methyltransferase cap binding. Journal of Molecular Biology. 385: 1643-54. PMID 19101564 DOI: 10.1016/J.Jmb.2008.11.058 |
0.625 |
|
| 2009 |
Thompson A, Patel K, Tillman H, McHutchison JG. Directly acting antivirals for the treatment of patients with hepatitis C infection: a clinical development update addressing key future challenges. Journal of Hepatology. 50: 184-194. PMID 19022518 DOI: 10.1016/J.Jhep.2008.10.011 |
0.336 |
|
| 2009 |
Thompson A, Elliott L, Tillmann H, McHutchison J, Patel K. 423 PAIRED BIOPSY COMPARISON OF TWO LIVER FIBROSIS MARKER PANELS (HCV FIBROTEST, HEPASCORE) IN FOLLOWING HISTOLOGICAL RESPONSE TO ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS C (CHC) Journal of Hepatology. 50: S159. DOI: 10.1016/S0168-8278(09)60425-6 |
0.316 |
|
| 2008 |
Preiss S, Littlejohn M, Angus P, Thompson A, Desmond P, Lewin SR, Sasadeusz J, Matthews G, Dore GJ, Shaw T, Sozzi V, Yuen L, Lau G, Ayres A, Thio C, et al. Defective hepatitis B virus DNA is not associated with disease status but is reduced by polymerase mutations associated with drug resistance. Hepatology (Baltimore, Md.). 48: 741-9. PMID 18571815 DOI: 10.1002/Hep.22386 |
0.309 |
|
| 2007 |
Thompson AA, Albertini RA, Peersen OB. Stabilization of poliovirus polymerase by NTP binding and fingers-thumb interactions. Journal of Molecular Biology. 366: 1459-74. PMID 17223130 DOI: 10.1016/J.Jmb.2006.11.070 |
0.618 |
|
| 2006 |
Tellez AB, Crowder S, Spagnolo JF, Thompson AA, Peersen OB, Brutlag DL, Kirkegaard K. Nucleotide channel of RNA-dependent RNA polymerase used for intermolecular uridylylation of protein primer. Journal of Molecular Biology. 357: 665-75. PMID 16427083 DOI: 10.1016/J.Jmb.2005.12.044 |
0.615 |
|
| 2006 |
Thompson A, Chadwick OA, Rancourt DG, Chorover J. Iron-oxide crystallinity increases during soil redox oscillations Geochimica Et Cosmochimica Acta. 70: 1710-1727. DOI: 10.1016/J.Gca.2005.12.005 |
0.306 |
|
| 2005 |
Bell SJ, Lau A, Thompson A, Watson KJ, Demediuk B, Shaw G, Chen RY, Ayres A, Yuen L, Bartholomeusz A, Locarnini SA, Desmond PV. Chronic hepatitis B: recommendations for therapy based on the natural history of disease in Australian patients. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 32: 122-7. PMID 15653414 DOI: 10.1016/J.Jcv.2004.10.009 |
0.331 |
|
| 2004 |
Thompson AA, Peersen OB. Structural basis for proteolysis-dependent activation of the poliovirus RNA-dependent RNA polymerase. The Embo Journal. 23: 3462-71. PMID 15306852 DOI: 10.1038/Sj.Emboj.7600357 |
0.616 |
|
| Show low-probability matches. |